Abstract

Aim. To improve the long-term outcomes of patients with atrial fibrillation (AF) after cardioembolic stroke by creating and testing a comprehensive ambulatory monitoring system.Material and methods. The present study included 139 AF patients after cardioembolic stroke for the period 2016-2019, of which 80 (57,55%) were women and 59 (42,45%) were men. The mean age of the patients was 72,25±6,33years. Before the hospital discharge, all patients signed an informed consent and were randomized into two groups. Patients of the group I (n=72) were followed up during the year in accordance with a specially developed comprehensive ambulatory monitoring system. This system included a rehabilitation program created individually for each patient, monthly visits to a physician-researcher, during which a complex of diagnostic tests was carried out. Also, the changes of complaints, symptoms, and medical adherence were assessed. The latter was corrected. A physician talked with the patient's relatives about the need to comply with the recommended medication regimen, supporting the motivation for treatment. Patients of group II (n=67) were followed up at the primary care level in accordance with the current program, and a control visit to was performed for them once — after 12 months.Results. After one-year follow-up, a significant decrease in all-cause mortality was obtained in the first group in comparison with the second one: 3 (4,17%) and 18 (26,87%) deaths, respectively (p=0,021).In addition, in group II, a relationship was found between the death and absence of anticoagulant therapy (odds ratio, 7,68; 95% confidence interval, 1,59-37,03; p=0,01). The ROC analysis confirmed the relationship between the absence of anticoagulant therapy and death, while the regression quality was good (area under the curve, 0,77, sensitivity — 94,74%, specificity — 59,17%).Conclusion. Comprehensive ambulatory monitoring program for AF patients after cardioembolic stroke has proven high effectiveness, and its widespread practice is an urgent task of modern healthcare.

Highlights

  • В группе II выявлена зависимость возникновения смертельного исхода с отсутствием приема антикоагулянтной терапии (ОШ 7,68; 95% доверительный интервал 1,59-37,03; p=0,01)

  • О целесообразности широкого внедрения именно такого подхода к амбулаторному этапу реабилитации свидетельствуют и результаты нашего исследования — при ведении пациентов в соответствии с разработанной комплексной системой амбулаторного мониторинга в течение года после выписки из специализированного стационара было получено статистически значимое снижение первичной комбинированной конечной точки (сердечно-сосудистая смерть, инфаркта миокарда (ИМ), ишемический инсульт), а также таких вторичных точек эффективности, как общая смертность и госпитализация вследствие декомпенсации хронической сердечной недостаточности (ХСН)

Read more

Summary

Introduction

И.* — соискатель кафедры кардиологии и сердечно-сосудистой хирургии Института профессионального образования; врач терапевт-кардио­ лог неврологического отделения для больных с острыми нарушениями мозгового кровообращения (ПСО), ORCID: 0000-0002-7670-3568, Павлова Т. В. — д.м.н., профессор кафедры кардиологии и сердечно-сосудистой хирургии Института профессионального образования, ORCID: 0000-0003-3301-1577, Пыщева Л.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call